Evidence map›Paper›PMID 40591193›Full record

ReviewTopics in current chemistry (Cham)2025

Recent Advances in Synthetic Strategies and Biological Properties of Indazole Scaffolds: A Review.

S N Murthy Boddapati, Bhuvaneswari Chalapaka, Abraham Emmanuel Kola, Sreekantha Babu Jonnalagadda

Abstract readReview
In one paragraph

Review in Topics in current chemistry (Cham), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S N Murthy BoddapatiSchool of Chemistry & Physics, College of Agriculture, Engineering & Science, University of KwaZulu-Natal, Westville Campus, P Bag X 54001, Durban, 4000, South Africa. snmurthyboddapati@gmail.com.ORCID https://orcid.org/0000-0002-0703-9827
Bhuvaneswari ChalapakaDepartment of Chemistry, Adikavi Nannaya University, Rajamahendravaram, A.P., India.ORCID https://orcid.org/0000-0002-7540-3352
Abraham Emmanuel KolaDepartment of Chemistry, Y.V.N.R Government Degree College, Kaikaluru, A.P., India.ORCID https://orcid.org/0000-0001-6498-7957
Sreekantha Babu JonnalagaddaSchool of Chemistry & Physics, College of Agriculture, Engineering & Science, University of KwaZulu-Natal, Westville Campus, P Bag X 54001, Durban, 4000, South Africa. Jonnalagaddas@ukzn.ac.za.ORCID https://orcid.org/0000-0001-6501-8875

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research on heterocyclic compounds is an area of continuous focus, capturing the interest of both synthetic and natural product chemists. Indazoles are one of the rare heterocycles that are available in nature. Indazole and its derivatives are one of the most important classes of heterocycles in pharmacological molecules. The structurally different indazole motifs, with impressive bioactivity, have drawn increasing attention from medicinal chemists in recent years for the continuous development of novel drug moieties. Thus, knowledge of the biological activities and synthetic pathways of indazole scaffolds is essential to enhancing further developments in the number of indazole-based lead molecules. The goal of the present review is to highlight information on the biological properties of some existing indazole-based drugs and activities of novel bioactive indazole compounds in clinical trails, with specific attention to the most recent advances in various synthetic strategies towards indazole and its derivatives over the past 7 years (2017-2024). Moreover, we discuss the substrate tolerance and mechanistic insights for most of the summarized synthetic protocols.

Indexed as

IndazolesHumansMolecular StructureIndazolesBiological activitiesClinical trailsHeterocyclesIndazoleMechanistic insightsSynthetic routes

Identifiers

PMID40591193
PMCPMC12213994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.